Patents by Inventor Per GREISEN

Per GREISEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240082316
    Abstract: Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating diseases associated with hyperphenylalaninemia are disclosed.
    Type: Application
    Filed: August 9, 2023
    Publication date: March 14, 2024
    Inventors: Kristin ADOLFSEN, Per GREISEN, Isolde CALLIHAN, Adam LAWRENCE, James SPOONAMORE, Jay KONIECZKA
  • Patent number: 11766463
    Abstract: Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating diseases associated with hyperphenylalaninemia are disclosed.
    Type: Grant
    Filed: June 3, 2022
    Date of Patent: September 26, 2023
    Assignee: Synlogic Operating Company, Inc.
    Inventors: Kristin Adolfsen, Per Greisen, Isolde Callihan, Adam Lawrence, James Spoonamore, Jay Konieczka
  • Publication number: 20220362309
    Abstract: Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating diseases associated with hyperphenylalaninemia are disclosed.
    Type: Application
    Filed: June 3, 2022
    Publication date: November 17, 2022
    Inventors: Kristin ADOLFSEN, Per GREISEN, Isolde CALLIHAN, Adam LAWRENCE, James SPOONAMORE, Jay KONIECZKA
  • Publication number: 20220025003
    Abstract: The present disclosure provides danoprevir/NS3a complex reader (DNCR) and grazoprevir/NS3a complex readers (GNCR) polypeptides, fusion proteins, and combinations and their use.
    Type: Application
    Filed: December 3, 2019
    Publication date: January 27, 2022
    Inventors: David BAKER, Daniel CUNNINGHAM-BRYANT, Emily DIETER, Glenna FOIGHT, Per GREISEN, Dustin MALY, Keunwan PARK, Zhizhi WANG, Cindy WEI